Genitourinary Cancer Treatment Center
Dana-Farber’s Lank Center for Genitourinary Oncology provides compassionate care and the most effective therapies for prostate, kidney, and testicular cancer, as well as many other rare and common cancers. Staffed by medical, urologic, and radiation oncologists, our center offers the latest treatments fueled by ongoing discovery.
About the Lank Center for Genitourinary Oncology
At Dana-Farber's Lank Center for Genitourinary Oncology, we want our patients to receive the safest, best treatment for their cancer. Our center provides compassionate care that is informed by research into the most effective therapies.
We know you face challenges which extend into family, work and other responsibilities. That knowledge guides how our team of specialists works with you to create a care plan that takes your individual goals and needs into account.
Our team will build a treatment plan tailored to your cancer, based on the latest surgical, chemotherapy, and radiation treatment approaches, including access to clinical trials.
In addition to offering the latest in clinical care, we provide a wide range of resources — from support groups to nutritional advice to complementary therapies — to support you physically and emotionally throughout your treatment.
We also offer Patient Navigation, which can assist you as you move through the cancer care continuum. Patient Navigation can help with arranging various forms of financial support, scheduling transportation to and from appointments, organizing child care during appointments, and more. Our GU Patient Navigator provides education about prostate cancer and treatment options, and upon request, will sit with you before, during and after your consultations with our clinicians.
Our clinicians are experts in treating all types of genitourinary cancer, including:
- Adrenal cancer
- Adrenocortical carcinoma
- Bladder cancer
- Germ cell testicular cancer
- Kidney tumor
- Penile cancer
- Prostate cancer
- Renal cell cancer
- Rhabdoid tumor of the kidney
- Testicular cancer (seminoma and non-seminoma)
- Testicular choriocarcinoma
- Transitional cell cancer
- Urethral cancer
- Urachal cancer
- Ureteral cancer
- Urothelial cancer
- Wilms' kidney tumor
Our Treatment Approach
Staffed by medical, urologic, and radiation oncologists, our center offers the latest treatments fueled by ongoing discovery. Our genitourinary cancer experts work together to create an individualized treatment plan that offers each patient the most effective care.
During your first appointment at the center, you'll get a thorough consultation to help determine the best course of treatment for your cancer.
You will have the opportunity to meet with up to three specialists: medical oncologist, radiation oncologist, and urologist. Working with you, these experts will evaluate, discuss, and recommend specific treatments to create a care plan that takes your individual needs into account.
Our team also includes radiologists, pathologists, nurse specialists, social workers, palliative care specialists, psychologists and psychiatrists, sexual health experts, and dietitians. Working together, we provide expert diagnostic services and innovative treatment options, including:
- Robotic surgery
- Intraoperative magnetic resonance therapy
- Dose-escalated intensity modulated radiation therapy, delivered with a unique prostate localization and immobilization device
- Innovative treatment combinations, including hormone therapy and chemotherapy combined with radiation therapy, conducted as part of rigorously-controlled clinical trials
- Clinical trials of new cancer therapies
We also run several laboratories that are investigating the molecular basis of all genitourinary malignancies. These research efforts are vital, because basic science is a crucial component in the treatment of cancer. Understanding the basic mechanisms of disease will ultimately translate into better treatment for our patients.
The Lank Center for Genitourinary Oncology includes some of the world's top researchers and clinicians in genitourinary cancer.
Toni Choueiri, MD, Director
Joaquim Bellmunt, MD
Atish Choudhury, MD, PhD
William C. Hahn, MD, PhD
Lauren C. Harshman, MD
Elizabeth Henske, MD
Franklin Huang, MD, PhD
Kerry Laing Kilbridge, MD
Bradley A. McGregor, MD
Mark Pomerantz, MD
Christopher Sweeney, MBBS
David Takeda, MD, PhD
Mary-Ellen Taplin, MD
Eliezer Van Allen, MD
Matthew Vander Heiden, MD, PhD
Rachel Allende, LICSW (Spanish- and Portuguese-speaking patients)
Bruce MacDonald, LICSW
Mary (Molly) McHugh, LCSW (inpatients)
Lauren Engel, NP
Alexandra Mulloy, NP
Mark Yoder, NP
Allison Taylor, NP
DeeDee McDonald, RN
Mary O'Driscoll, RN
Karen Polinski, RN, MEd, OCN
Marian Loffredo RN, BS, OCN
Elizabeth McMahon, RN
Clinical Research Nurses
Amanda Pace, RN, BSN
Judith Prisby, RN, BSN, OCN
Meghara Walsh, RN, BSN
Clare Tempany, MD
We conduct clinical research and investigations to improve our ability to diagnose and treat patients with all genitourinary malignancies. This research is important, because it aims to improve current and future cancer treatments and care.
Our physicians and researchers conduct ongoing research studies, including:
- investigations of prevention and early-detection strategies
- assessment of new therapies
- quality-of-life studies
- analysis of tissue, blood, and tumor samples to better understand the biology of the malignancies and relation to patient outcomes
If you are a new patient, we may ask you to participate in one of these studies. Learn more about participating in a clinical trial.
The Arthur and Linda Gelb Center for Translational Research
With the cooperation of more than 8,000 patients, the Arthur and Linda Gelb Center for Translational Research has steadily built a deep clinical database and collection of genitourinary cancer samples.
Research using these samples has yielded significant data about the development and treatment of prostate, renal, and bladder cancers, helping scientists study possible links between genes and genitourinary cancers.
Such efforts are designed to develop better, more effective treatments for cancer and related malignancies.
Learn more about the Gelb Center.
Prostate and renal cancer research studies
As a Dana-Farber patient, you may be asked to participate in a research study designed to help doctors and scientists understand the basic biology and genetics of prostate and renal cancer, which ultimately may help people in the future.
During your appointment, a study coordinator will meet with you to discuss the study and answer your questions. Your participation is completely voluntary and will not affect your medical care or benefits should you decide not to participate.
Find out more about prostate and renal cancer research studies.
If you have never been seen before at Dana-Farber/Brigham and Women's Cancer Center, please call 877-442-3324 or use this online form to make an appointment.
You may schedule your first appointment for as soon as the next day. After scheduling, one of our nurses will call you to answer your questions and help you prepare for the appointment.
For other patient questions or information, call us at 617-632-3466.
New patients and referring physicians: 617-632-2557
Established patients: 617-632-2165
Dana-Farber Cancer Institute
Lank Center for Genitourinary Oncology
450 Brookline Ave.
Boston, MA 02215-5450